Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Eton Pharmaceuticals Inc is a biotechnology business based in the US. Eton Pharmaceuticals shares (ETON) are listed on the NASDAQ and all prices are listed in US Dollars. Eton Pharmaceuticals employs 17 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
| Latest market close | $2.66 |
|---|---|
| 52-week range | $2.47 - $6.72 |
| 50-day moving average | $3.16 |
| 200-day moving average | $4.08 |
| Wall St. target price | $10.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.49 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.66 from 2022-07-06
| 1 week (2022-06-30) | 1.53% |
|---|---|
| 1 month (2022-06-03) | N/A |
| 3 months (2022-04-06) | -37.12% |
| 6 months (2022-01-03) | -43.28% |
| 1 year (2021-07-07) | -54.22% |
|---|---|
| 2 years (2020-07-07) | -50.19% |
| 3 years (2019-07-05) | 7.72 |
| 5 years (2017-07-03) | N/A |
| Revenue TTM | $12.1 million |
|---|---|
| Gross profit TTM | $19.2 million |
| Return on assets TTM | -27.46% |
| Return on equity TTM | -70.99% |
| Profit margin | -102.39% |
| Book value | $0.54 |
| Market capitalisation | $65.8 million |
TTM: trailing 12 months
We're not expecting Eton Pharmaceuticals to pay a dividend over the next 12 months.
Over the last 12 months, Eton Pharmaceuticals's shares have ranged in value from as little as $2.47 up to $6.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eton Pharmaceuticals's is 1.4259. This would suggest that Eton Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Eton Pharmaceuticals, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.